HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Graduate School of Health Sciences / Faculty of Health Sciences >
Peer-reviewed Journal Articles, etc >

Pharmaceutical immunoglobulins reduce neutrophil extracellular trap formation and ameliorate the development of MPO-ANCA-associated vasculitis

Files in This Item:
Ishizu2019.pdf1.89 MBPDFView/Open
Please use this identifier to cite or link to this item:http://hdl.handle.net/2115/78182

Title: Pharmaceutical immunoglobulins reduce neutrophil extracellular trap formation and ameliorate the development of MPO-ANCA-associated vasculitis
Authors: Uozumi, Ryo Browse this author
Iguchi, Risa Browse this author
Masuda, Sakiko Browse this author
Nishibata, Yuka Browse this author
Nakazawa, Daigo Browse this author
Tomaru, Utano Browse this author →KAKEN DB
Ishizu, Akihiro Browse this author →KAKEN DB
Keywords: ANCA-associated vasculitis
Animal model
Anti-neutrophil cytoplasmic antibody (ANCA)
Intravenous immunoglobulin (IVIG)
Neutrophil extracellular traps (NETs)
Issue Date: 12-Apr-2019
Publisher: Taylor & Francis
Journal Title: Modern Rheumatology
Volume: 30
Issue: 3
Start Page: 544
End Page: 550
Publisher DOI: 10.1080/14397595.2019.1602292
PMID: 30932727
Abstract: Objectives: Intravenous immunoglobulin (IVIG) therapy is effective against some autoimmune diseases. Although its efficacy on peripheral neuropathy due to eosinophilic granulomatosis with polyangiitis-one of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis (MPO-AAV)-has been established, that on other MPO-AAV remains undetermined. We examined the effects of pharmaceutical immunoglobulins on the formation of neutrophil extracellular traps (NETs) related to MPO-ANCA production and the development of MPO-AAV. Methods: Peripheral blood neutrophils from healthy volunteers were pretreated with 5 mg/ml human sulfo-immunoglobulins (IVIG-S) and then exposed to 100 nM phorbol myristate acetate (PMA). Thereafter, neutrophils were stained with SYTOX Green and then subjected to flow cytometry. Next, Wistar-Kyoto rats were given oral administration of 10 mg/kg/day propylthiouracil for 28 days and intraperitoneal (i.p.) injection of 1 µg PMA on days 0 and 7. These rats were divided into two groups: Group 1 with i.p. injection of 400 mg/kg IVIG-S on days 8-12 and Group 2 with i.p. injection of vehicle similarly. ANCA titers were chronologically determined by indirect immunofluorescence. On day 28, all rats were killed to examine NET formation in the peritoneum and the development of AAV. Results: IVIG-S significantly inhibited NET formation induced by PMA in vitro. NET amounts in the peritoneum in Group 1 were significantly smaller than in Group 2, and ANCA titers in Group 1 were significantly lower than in Group 2. The degree of pulmonary hemorrhage in Group 1 was also smaller than in Group 2. Conclusion: Pharmaceutical immunoglobulins reduce NET formation and ameliorate the development of MPO-AAV.
Rights: This is an Accepted Manuscript of an article published by Taylor & Francis in Modern Rheumatology on 12 Apr 2019, available online: http://www.tandfonline.com/10.1080/14397595.2019.1602292.
Type: article (author version)
URI: http://hdl.handle.net/2115/78182
Appears in Collections:保健科学院・保健科学研究院 (Graduate School of Health Sciences / Faculty of Health Sciences) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Submitter: 石津 明洋

Export metadata:

OAI-PMH ( junii2 , jpcoar )

MathJax is now OFF:


 

 - Hokkaido University